| 2024-04-19 | Sale | PTC Therapeutics, Inc. PTCT | CHIEF EXECUTIVE OFFICER | 3,361 0.0043% | $24.89 | $83,669 | +38.82% | |
| 2024-04-17 | Sale | PTC Therapeutics, Inc. PTCT | CHIEF EXECUTIVE OFFICER | 1,307 0.0017% | $25.14 | $32,851 | +39.22% | |
| 2024-01-09 | Sale | PTC Therapeutics, Inc. PTCT | CHIEF EXECUTIVE OFFICER | 5,443 0.0073% | $29.01 | $157,928 | +1.03% | |
| 2024-01-08 | Sale | PTC Therapeutics, Inc. PTCT | CHIEF EXECUTIVE OFFICER | 2,237 0.0029% | $28.64 | $64,068 | -2.52% | |
| 2024-01-05 | Sale | PTC Therapeutics, Inc. PTCT | CHIEF EXECUTIVE OFFICER | 10,107 0.013% | $27.15 | $274,393 | +3.79% | |
| 2023-04-18 | Sale | PTC Therapeutics, Inc. PTCT | CHIEF EXECUTIVE OFFICER | 1,211 0.0016% | $52.04 | $63,025 | -45.58% | |
| 2023-01-11 | Sale | PTC Therapeutics, Inc. PTCT | CHIEF OPERATING OFFICER | 2,244 0.003% | $44.36 | $99,543 | -10.64% | |
| 2023-01-10 | Sale | PTC Therapeutics, Inc. PTCT | CHIEF OPERATING OFFICER | 2,273 0.003% | $42.93 | $97,586 | -7.69% | |
| 2023-01-09 | Sale | PTC Therapeutics, Inc. PTCT | CHIEF OPERATING OFFICER | 731 0.001% | $41.66 | $30,451 | -1.32% | |
| 2022-04-19 | Sale | PTC Therapeutics, Inc. PTCT | CHIEF OPERATING OFFICER | 897 0.0012% | $42.52 | $38,136 | +2% | |
| 2022-01-07 | Sale | PTC Therapeutics, Inc. PTCT | Chief Operating Officer | 775 0.0011% | $38.52 | $29,857 | +5.33% | |
| 2021-04-20 | Sale | PTC Therapeutics, Inc. PTCT | Chief Development Officer | 1,641 0.0024% | $46.74 | $76,704 | -13.86% | |
| 2021-04-19 | Sale | PTC Therapeutics, Inc. PTCT | Chief Development Officer | 859 0.0012% | $48.17 | $41,376 | -16.09% | |
| 2021-01-15 | Sale | PTC Therapeutics, Inc. PTCT | Chief Development Officer | 4,300 0.0062% | $69.09 | $297,078 | -39.79% | |
| 2021-01-08 | Sale | PTC Therapeutics, Inc. PTCT | Chief Development Officer | 5,500 0.0081% | $69.71 | $383,410 | -38.46% | |
| 2021-01-07 | Sale | PTC Therapeutics, Inc. PTCT | Chief Development Officer | 3,886 0.0055% | $68.98 | $268,056 | -39.65% |